Gossamer Bio (GOSS) Payables: 2022-2025
Historic Payables for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to $1.1 million.
- Gossamer Bio's Payables fell 63.49% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.7 million, marking a year-over-year decrease of 28.94%. This contributed to the annual value of $2.3 million for FY2024, which is 58.03% down from last year.
- Latest data reveals that Gossamer Bio reported Payables of $1.1 million as of Q3 2025, which was down 40.51% from $1.9 million recorded in Q2 2025.
- Over the past 5 years, Gossamer Bio's Payables peaked at $5.5 million during Q4 2023, and registered a low of $363,000 during Q3 2022.
- Moreover, its 3-year median value for Payables was $2.3 million (2024), whereas its average is $2.5 million.
- In the last 5 years, Gossamer Bio's Payables skyrocketed by 361.32% in 2023 and then crashed by 63.49% in 2025.
- Gossamer Bio's Payables (Quarterly) stood at $1.5 million in 2022, then skyrocketed by 278.75% to $5.5 million in 2023, then plummeted by 58.03% to $2.3 million in 2024, then slumped by 63.49% to $1.1 million in 2025.
- Its last three reported values are $1.1 million in Q3 2025, $1.9 million for Q2 2025, and $3.4 million during Q1 2025.